Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02624700
Title Study of Pemetrexed and Sorafenib for Recurrent or Metastatic Triple Negative Breast Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Virginia Commonwealth University
Indications

triple-receptor negative breast cancer

Therapies

Pemetrexed Disodium + Sorafenib

Age Groups: adult
Covered Countries USA


No variant requirements are available.